DJIA 17,672.60 -141.38 -0.79%
NASDAQ 4,757.88 7.48 0.16%
S&P 500 2,051.82 -11.33 -0.55%
market minute promo

Gilead Sciences (NASDAQ: GILD)

105.54 0.40 (0.38%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

GILD $105.54 0.38%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $104.40
Previous Close $105.14
Daily Range $103.80 - $106.11
52-Week Range $63.50 - $116.83
Market Cap $159.2B
P/E Ratio 18.64
Dividend (Yield) $0.00 (0.0%)
Volume 9,584,751
Average Daily Volume 19,566,349
Current FY EPS $7.80

Sector

Healthcare

Industry

Drugs

Gilead Sciences (GILD) Description

Gilead Sciences created and sells the world’s top-selling HIV medications, Truvada and Atripla, and commands about 75% of the U.S. treatment market and more than 50% worldwide. Website: http://www.gilead.com/

News & Commentary

Here's Why This Year's Flu Vaccine Isn't Working

Have you ever wondered why the effectiveness of the flu vaccine is so erratic from one year to the next? Here's the answer.

IWF, GILD, PEP, ORCL: Large Outflows Detected at ETF

3 Attractive Biotech Picks For 2015

Gilead Sciences Still has More Upside

Has Gilead Sciences Been Able To Maintain Its Lead Run In The Face Of Competition?

Healthcare ETFs in Focus on Mixed JNJ Results - ETF News And Commentary

Deutsche Bank Comments On Concerns Over Consensus Estimates For AbbVie And Gilead Sciences

Stocks Stage Late Rally Ahead of Thursday's ECB Decision

Biotech Stock Roundup: EU Approvals for AbbVie & Celgene Drugs, CytRx Partial Clinical Hold Lifted -

Biotech Stock Roundup: EU Approvals for AbbVie & Celgene Drugs, CytRx Partial Clinical Hold Lifted - Analyst Blog

Cramer's Lightning Round - No Panic Over Gilead (1/20/15)

See More GILD News...

GILD's Top Competitors

GILD $105.54 (0.38%)
Current stock: GILD
AMGN $159.81 (0.15%)
Current stock: AMGN
CELG $123.89 (0.15%)
Current stock: CELG
$0.00 (0.00%)
Current stock: